Dengue Vaccines: Challenge and Confrontation

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

World Journal of Vaccines

ISSN Print: 2160-5815
ISSN Online: 2160-5823
www.scirp.org/journal/wjv
E-mail: wjv@scirp.org

Google-based Impact Factor: 0.86
Citations h5-index & Ranking*

Journals Menu

"Dengue Vaccines: Challenge and Confrontation"
written by Guey Chuen Perng, Huan-Yao Lei, Yee-Shin Lin, Kulkanya Chokephaibulkit,
published by World Journal of Vaccines, Vol.1 No.4, 2011

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Suppressed humoral immunity is associated with dengue nonstructural protein NS1-elicited anti-death receptor antibody fractions in mice
	2020

[2]	Advancements in developing an effective and preventive dengue vaccine
	2020

[3]	Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development
	2020

[4]	Dengue Vaccine: A Road to Dengue Prevention
	2018

[5]	Prevention and Control Strategies to Counter Dengue Virus Infection
	Frontiers in cellular and infection microbiology, 2017

[6]	Winner-take-all, take-most or pay-some? Optimal protection of innovation in a dynamic model of product development
	SSRN, 2017

[7]	A Study on Performance Evaluation and Utility of RT-LAMP (Reverse transcription loop-mediated isothermal amplification assay) for early detection of Dengue fever …
	2017

[8]	Effect of different anti-aflatoxin antibody isotypes on biosensor and immunoaffinity column performance
	2016

[9]	Evaluación in vitro del efecto antiviral de compuestos derivados de plantas de la Región Caribe Colombiana sobre la infección por Virus Dengue y Virus …
	2016

[10]	AB Initio Structural Analysis on Envelope (E) Glycoprotein of Dengue Virus (DENV) Type 1-4
	UK Journal of Pharmaceutical and Biosciences, 2016

[11]	DEVELOPMENT OF DNA ELECTROCHEMICAL SENSOR BASED ON SILICON NANOWIRES/GOLD NANOPARTICLES-MODIFED ELECTRODE FOR EARLY …
	2016

[12]	On the optimal timing of innovation and imitation
	2016

[13]	When should a winner take all, or pay some? Innovation and imitation incentives in a dynamic duopoly
	2016

[14]	Vaccinations for travel
	2015

[15]	Dengue vaccines: Challenges, development, current status and prospects
	Indian journal of medical microbiology, 2015

[16]	Dengue risk assessment
	2015

[17]	On the timing of innovation and imitation
	2015

[18]	Anti-idiotype antibody against pre-membrane-specific antibody as an adjunct to current dengue vaccination strategy
	2015

[19]	B?LüM 9 H?BR?DOMA TEKNOLOJ?S?
	2015

[20]	Vaccine development against dengue, a viral disease of increasing significance to global public health
	2014

[21]	Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1
	PloS one, 2014

[22]	Innovation and imitation incentives in dynamic duopoly
	Document de travail，Université de Lille, 2014

[23]	Protection against Dengue Virus Infection in Mice by Administration of Antibodies
	2014

[24]	Laboratory Diagnosis of Dengue Infection: Current Techniques and Future Strategies
	Open Journal of Clinical Diagnostics, 2014

[25]	Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome
	Journal of biomedical science, 2013

[26]	Current progress in dengue vaccines
	J Biomed Sci, 2013

[27]	Challenges for the formulation of a universal vaccine against dengue
	Experimental Biology and Medicine, 2013

[28]	Anti–Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3β and NF-κB Activation
	The Journal of Immunology, 2013

[29]	Лихорадка Денге у российских туристов, прибывших из Таиланда
	2013

[30]	Anti–Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3β and …
	2013

[31]	Anti–Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3β and …
	2013

[32]	This information is current as Activation
	2013

[33]	Результаты поиска: 0
	2013

[34]	Dengue fever in Russian tourists who have come from Thailand
	2013

[35]	Role of microparticles in dengue virus infection and its impact on medical intervention strategies
	The Yale journal of biology and medicine, 2012

[36]	Evaluation of the Kinetic Change of the Immunogenicity of Dengue-2 DNA Vaccine in Mice Administered by Different Administration Routes
	World Journal of Vaccines, 2012

[1]	Vaccination effect on the dynamics of dengue disease transmission models in Nepal: A fractional derivative approach Partial Differential Equations in Applied Mathematics, 2023 DOI:10.1016/j.padiff.2022.100476

[2]	Vaccination effect on the dynamics of dengue disease transmission models in Nepal: A fractional derivative approach Partial Differential Equations in Applied Mathematics, 2023 DOI:10.1016/j.padiff.2022.100476

[3]	Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development Viruses, 2020 DOI:10.3390/v12111261

[4]	Advancements in developing an effective and preventive dengue vaccine Future Virology, 2020 DOI:10.2217/fvl-2019-0080

[5]	Prevention and Control Strategies to Counter Dengue Virus Infection Frontiers in Cellular and Infection Microbiology, 2017 DOI:10.3389/fcimb.2017.00336

[6]	Dengue vaccines: Challenges, development, current status and prospects Indian Journal of Medical Microbiology, 2015 DOI:10.4103/0255-0857.148369

[7]	Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1 PLoS ONE, 2014 DOI:10.1371/journal.pone.0092495

[8]	Laboratory Diagnosis of Dengue Infection: Current Techniques and Future Strategies Open Journal of Clinical Diagnostics, 2014 DOI:10.4236/ojcd.2014.41012

[9]	Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome Journal of Biomedical Science, 2013 DOI:10.1186/1423-0127-20-88

[10]	Viral Hemorrhagic Fevers 2013 DOI:10.1201/b15172-29

[11]	Challenges for the formulation of a universal vaccine against dengue Experimental Biology and Medicine, 2013 DOI:10.1177/1535370212473703

[12]	Anti–Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3β and NF-κB Activation The Journal of Immunology, 2013 DOI:10.4049/jimmunol.1201976

[13]	Current progress in dengue vaccines Journal of Biomedical Science, 2013 DOI:10.1186/1423-0127-20-37

[14]	Anti–Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3β and NF-κB Activation The Journal of Immunology, 2013 DOI:10.4049/jimmunol.1201976

[15]	Evaluation of the Kinetic Change of the Immunogenicity of Dengue-2 DNA Vaccine in Mice Administered by Different Administration Routes World Journal of Vaccines, 2012 DOI:10.4236/wjv.2012.22009

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

World Journal of Vaccines

World Journal of Vaccines

Journals Menu

Home

About SCIRP

Service

Policies